Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs

Today, 1:31 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22)

ACOR

7 minute read

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street

By Shanthi Rexaline

Today, 1:31 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19)

ABIO

5 minute read

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study

By Shanthi Rexaline

Today, 1:31 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15)

ABCL

11 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 1:31 PM

During the morning session on Thursday, 152 stocks hit new 52-week lows.

ABCL

6 minute read

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs

By Shanthi Rexaline

Today, 1:31 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14)

ABCL

1 minute read

Vor Biopharma, Janssen Team Up To Develop Combination Therapies For Acute Myeloid Leukemia

By Vandana Singh

Today, 1:31 PM

Vor Biopharma Inc (NASDAQ:VOR) has collaborated with Janssen Biotech Inc, a unit of Johnson & Johnson (NYSE:JNJ). Under the terms of the collaboration,…

JNJ

1 minute read

Vor Biopharma Announces Collaboration With Janssen To Develop Engineered Hematopoietic Stem Cell Transplants Combined With A Bi-Specific Antibody Therapy For Acute Myeloid Leukemia; Financial Details Not Disclosed

By Bill Haddad

Today, 1:31 PM

Vor Biopharma (NASDAQ:VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced the formation of a

JNJ